Literature DB >> 10633033

Cyclin-dependent kinase inhibitors: useful targets in cell cycle regulation.

T M Sielecki1, J F Boylan, P A Benfield, G L Trainor.   

Abstract

Mesh：

Substances：

Year:  2000        PMID： 10633033

Source DB:  PubMed          Journal:  J Med Chem        ISSN： 0022-2623            Impact factor:   7.446


× No keyword cloud information.
  30 in total

1.  Inhibition of S-phase cyclin-dependent kinase activity blocks expression of Epstein-Barr virus immediate-early and early genes, preventing viral lytic replication.

Authors:  Ayumi Kudoh; Tohru Daikoku; Yutaka Sugaya; Hiroki Isomura; Masatoshi Fujita; Tohru Kiyono; Yukihiro Nishiyama; Tatsuya Tsurumi
Journal:  J Virol       Date:  2004-01       Impact factor: 5.103

2.  A validation study on the practical use of automated de novo design.

Authors:  Martin Stahl; Nikolay P Todorov; Tim James; Harald Mauser; Hans-Joachim Boehm; Philip M Dean
Journal:  J Comput Aided Mol Des       Date:  2002-07       Impact factor: 3.686

Review 3.  Molecular mechanisms of indirubin and its derivatives: novel anticancer molecules with their origin in traditional Chinese phytomedicine.

Authors:  Gerhard Eisenbrand; Frankie Hippe; Sandra Jakobs; Stephan Muehlbeyer
Journal:  J Cancer Res Clin Oncol       Date:  2004-08-31       Impact factor: 4.553

4.  Incorporating partial matches within multi-objective pharmacophore identification.

Authors:  Simon J Cottrell; Valerie J Gillet; Robin Taylor
Journal:  J Comput Aided Mol Des       Date:  2007-01-04       Impact factor: 3.686

Review 5.  Cheminformatics analysis and learning in a data pipelining environment.

Authors:  Moises Hassan; Robert D Brown; Shikha Varma-O'brien; David Rogers
Journal:  Mol Divers       Date:  2006-09-22       Impact factor: 2.943

6.  Proceedings of the 10th Asian Pacific Congress of Clinical Biochemistry in conjunction with the Australasian Association of Clinical Biochemists' 42nd Annual Scientific Conference.

Authors: 
Journal:  Clin Biochem Rev       Date:  2004

7.  Study of the inhibition of cyclin-dependent kinases with roscovitine and indirubin-3'-oxime from molecular dynamics simulations.

Authors:  Bing Zhang; Vincent B C Tan; Kian Meng Lim; Tong Earn Tay; Shulin Zhuang
Journal:  J Mol Model       Date:  2006-06-13       Impact factor: 1.810

8.  Molecular dynamics simulations on the inhibition of cyclin-dependent kinases 2 and 5 in the presence of activators.

Authors:  Bing Zhang; Vincent B C Tan; Kian Meng Lim; Tong Earn Tay
Journal:  J Comput Aided Mol Des       Date:  2006-10-13       Impact factor: 3.686

9.  Inhibition of cyclin-dependent kinase 1 by purines and pyrrolo[2,3-d]pyrimidines does not correlate with antiviral activity.

Authors:  David L Evers; Julie M Breitenbach; Katherine Z Borysko; Leroy B Townsend; John C Drach
Journal:  Antimicrob Agents Chemother       Date:  2002-08       Impact factor: 5.191

Review 10.  Marine pyrrolocarbazoles and analogues: synthesis and kinase inhibition.

Authors:  Sébastien Deslandes; Stefan Chassaing; Evelyne Delfourne
Journal:  Mar Drugs       Date:  2009-12-01       Impact factor: 5.118
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.